• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows

    7/1/24 1:38:37 PM ET
    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADBE alert in real time by email

    June closed on a high note for the stock market, with the S&P 500, tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY), gaining 3.2%, despite significant disparities in sector and industry performances.

    The technology sector, as tracked by the Technology Select Sector SPDR Fund (NYSE:XLK), led the 11 S&P 500 sectors in performance last month, surging 7.7% and achieving its strongest monthly gain this year.

    In stark contrast, utilities lagged, with the Utilities Select Sector SPDR Fund (NYSE:XLU) dropping 6.3%, marking the worst month since September 2023.

    Top Performing Industry ETFs In June

    The iShares Expanded Tech-Software Sector ETF (NYSE:IGV) rallied 11.3% last month, topping the rankings among industry ETFs.

    Hot on its heels was the VanEck Semiconductor ETF (NYSE:SMH), which climbed 8.4%, showcasing strong momentum in the semiconductor sector.

    Since hitting its low in October 2023, the VanEck Semiconductor ETF has rallied by an astounding 87%, and over 200% since October 2022, reflecting the spectacular growth in AI-driven stocks.

    Securing the third spot in terms of monthly performance, the SPDR S&P Biotech ETF (NYSE:XBI) gained 4%.

    Within the software sector, standout performers included Adobe Inc. (NASDAQ:ADBE), which surged by 24.9%, CrowdStrike Holdings, Inc. (NASDAQ:CRWD) with a 22.1% increase, and Oracle Corporation (NYSE:ORCL), up by 20%.

    Broadcom Inc. (NASDAQ:AVGO) led chipmakers with a 21% rise. Universal Display Corporation (NYSE:OLED) followed closely with a 19.7% increase, and Qorvo, Inc. (NASDAQ:QRVO) posted an 18% gain.

    Among chipmakers, Broadcom Inc. (NASDAQ:AVGO), Universal Display Corporation (NYSE:OLED) and Qorvo, Inc. (NASDAQ:QRVO) led gains, with performances of 21%, 19.7% and 18%, respectively.

    In the biotech arena, Scilex Holding Company (NASDAQ:SCLX) experienced a 78.8% spike, making it the top industry gainer. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) surged by 63.7%, while Avidity Biosciences, Inc. (NASDAQ:RNA) saw a robust 52% increase.

    Top Performing Industry ETFs By Inflows In June

    Examining fund flows, the VanEck Semiconductor ETF has emerged as a top choice for investors, attracting over $1 billion according to Tradingview data, and achieving its ninth consecutive month of inflows. Year-to-date the fund has registered $4.60 billion in net inflows.

    The iShares Expanded Tech-Software Sector ETF pulled in approximately $480 million in June, breaking a six-month streak of outflows and registering its highest monthly inflows since September 2022. Yet, its year-to-date net flows are still negative, down by $1.15 billion.

    The iShares Biotechnology ETF (NYSE:IBB) collected $148 million in inflows last month, reflecting strong investor interest. Another industry witnessing robust inflows was represented by the Global X Copper Miners ETF (NYSE:COPX), which attracted about $130 million.

    Read Next:

    • Manufacturing Contracts More Than Expected In June, ‘Putting Pressure On Profitability’: Yields Rise, Stocks Fall

    Photo: Shutterstock

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ALNY
    $AVGO
    $CRWD

    CompanyDatePrice TargetRatingAnalyst
    Qorvo Inc.
    $QRVO
    4/22/2026$100.00Equal Weight → Overweight
    Barclays
    CrowdStrike Holdings Inc.
    $CRWD
    4/21/2026$525.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Qorvo Inc.
    $QRVO
    4/20/2026$66.00Neutral → Underperform
    Mizuho
    Qorvo Inc.
    $QRVO
    4/17/2026Outperform → Peer Perform
    Wolfe Research
    Adobe Inc.
    $ADBE
    4/13/2026Neutral
    BTIG Research
    Oracle Corporation
    $ORCL
    4/10/2026Buy → Neutral
    Cleveland Research
    Broadcom Inc.
    $AVGO
    4/8/2026Buy → Neutral
    Seaport Research Partners
    Broadcom Inc.
    $AVGO
    4/3/2026Buy → Hold
    Erste Group
    More analyst ratings

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OXLUMO issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug OXLUMO (SUPPL-4) with active ingredient LUMASIRAN SODIUM has changed to 'Approval' on 09/19/2023. Application Category: NDA, Application Number: 214103, Application Classification: Labeling

    9/20/23 2:36:38 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for AMVUTTRA issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug AMVUTTRA (SUPPL-2) with active ingredient VUTRISIRAN has changed to 'Approval' on 02/16/2023. Application Category: NDA, Application Number: 215515, Application Classification: Labeling

    2/17/23 12:30:09 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CrowdStrike Launches Project QuiltWorks, Uniting the Cybersecurity Industry as Frontier AI Models Accelerate Risk

    Powered by frontier models from OpenAI and Anthropic, CrowdStrike's coalition includes Accenture, EY, IBM Cybersecurity Services, Kroll, and OpenAI to close the AI vulnerability gap for every enterprise CrowdStrike (NASDAQ:CRWD) today launched Project QuiltWorks, an industry-wide coalition of ecosystem partners to assess, prioritize, and continuously remediate the wave of vulnerabilities in production code now being discovered by frontier AI models. Project QuiltWorks includes Accenture, EY, IBM Cybersecurity Services, Kroll, OpenAI, CrowdStrike, and its broader partner ecosystem to help every organization answer the question their board is asking: are we exposed? To help organizations

    4/23/26 9:17:00 AM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

    SAN DIEGO, April 23, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (NASDAQ:RNA) (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics directly to the heart, announced today it has earned a $15 million development milestone payment from Bristol Myers Squibb (NYSE:BMY). The milestone was achieved upon the successful delivery of a development candidate for the first licensed compound targeting a cardiology indication under the Company's ongoing collaboration. "This milestone marks a meaningful step forward for Atrium, further expanding our RNA deliv

    4/23/26 8:00:00 AM ET
    $BMY
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Broadcom Expands Collaboration with Google Cloud on Cloud Network Insights

    LAS VEGAS, April 22, 2026 (GLOBE NEWSWIRE) -- Broadcom Inc. (NASDAQ:AVGO) today announced an expanded collaboration with Google Cloud on their new Cloud Network Insights service enabled by AppNeta by Broadcom. Cloud Network Insights provides end-to-end network observability to help organizations manage application and network experience, detect issues and diagnose root cause across complex, multi-cloud, hybrid and agentic environments. Building on its existing partnership with Broadcom, Google Cloud developed Cloud Network Insights as a first-party offering exclusively for Google Cloud users. With the deep network insights of Broadcom integrated with the scale of Google Cloud, Cloud Netwo

    4/22/26 9:00:00 AM ET
    $AVGO
    Semiconductors
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Qorvo upgraded by Barclays with a new price target

    Barclays upgraded Qorvo from Equal Weight to Overweight and set a new price target of $100.00

    4/22/26 7:43:34 AM ET
    $QRVO
    Semiconductors
    Technology

    CrowdStrike upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded CrowdStrike from Sector Weight to Overweight and set a new price target of $525.00

    4/21/26 7:28:06 AM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    Qorvo downgraded by Mizuho with a new price target

    Mizuho downgraded Qorvo from Neutral to Underperform and set a new price target of $66.00

    4/20/26 8:24:56 AM ET
    $QRVO
    Semiconductors
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT AND CEO Kurtz George sold $390,651 worth of shares (839 units at $465.62) as part of a pre-agreed trading plan, decreasing direct ownership by 0.04% to 2,218,973 units (SEC Form 4)

    4 - CrowdStrike Holdings, Inc. (0001535527) (Issuer)

    4/23/26 8:05:05 PM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    PRESIDENT AND CEO Kurtz George sold $1,890,709 worth of shares (4,161 units at $454.39) as part of a pre-agreed trading plan, decreasing direct ownership by 0.19% to 2,219,812 units (SEC Form 4)

    4 - CrowdStrike Holdings, Inc. (0001535527) (Issuer)

    4/23/26 8:00:06 PM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    Director Samueli Henry was granted 864 shares, increasing direct ownership by 25% to 4,356 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    4/23/26 4:30:10 PM ET
    $AVGO
    Semiconductors
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director You Harry L. bought $325,129 worth of shares (1,000 units at $325.13), increasing direct ownership by 3% to 36,602 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    12/22/25 5:34:40 PM ET
    $AVGO
    Semiconductors
    Technology

    Director You Harry L. bought $1,227,870 worth of shares (3,550 units at $345.88), increasing direct ownership by 11% to 35,602 units (SEC Form 4)

    4 - Broadcom Inc. (0001730168) (Issuer)

    9/10/25 9:07:35 PM ET
    $AVGO
    Semiconductors
    Technology

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    SEC Filings

    View All

    SEC Form DEFA14A filed by Universal Display Corporation

    DEFA14A - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer)

    4/23/26 4:05:02 PM ET
    $OLED
    Electrical Products
    Technology

    SEC Form DEF 14A filed by Universal Display Corporation

    DEF 14A - UNIVERSAL DISPLAY CORP \PA\ (0001005284) (Filer)

    4/23/26 4:00:20 PM ET
    $OLED
    Electrical Products
    Technology

    Broadcom Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Broadcom Inc. (0001730168) (Filer)

    4/21/26 4:37:02 PM ET
    $AVGO
    Semiconductors
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Financials

    Live finance-specific insights

    View All

    Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

    SAN DIEGO, April 23, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (NASDAQ:RNA) (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics directly to the heart, announced today it has earned a $15 million development milestone payment from Bristol Myers Squibb (NYSE:BMY). The milestone was achieved upon the successful delivery of a development candidate for the first licensed compound targeting a cardiology indication under the Company's ongoing collaboration. "This milestone marks a meaningful step forward for Atrium, further expanding our RNA deliv

    4/23/26 8:00:00 AM ET
    $BMY
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

    PALO ALTO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its Board of Directors (the "Scilex Board") approved a dividend of Dream Bowl I Meme Coin Tokens held by the Company (the "Dream Bowl Tokens") to its stockholders and certain other eligible equityholders of Scilex (collectively, the "Participating Holders"). The record date for the Dividend is April 30, 2026 (the "Record Date").

    4/20/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results

    Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2026 on Thursday, April 30, 2026, before the U.S. financial markets open. Management will provide an update on the Company and discuss first quarter 2026 results as well as expectations for the future via conference call on Thursday, April 30, 2026 at 8:30 am ET. A live audio webcast of the call will be available on the Investors section of the Company's website at www.alnylam.com/events. An archived webcast will be available on the Alnylam website approximately two hours after the event. About Alnylam Pharmaceut

    4/16/26 8:00:00 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Leadership Updates

    Live Leadership Updates

    View All

    Oracle Appoints Hilary Maxson as Chief Financial Officer

    AUSTIN, Texas, April 6, 2026 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced the appointment of Hilary Maxson as Chief Financial Officer (CFO). Maxson will report to Chief Executive Officer (CEO) Clay Magouyrk and lead the company's global finance organization, effective April 6, 2026. Maxson joins Oracle during a period of rapid growth as customer demand for cloud infrastructure exceeds supply. This growing demand for AI training and inferencing, multicloud database, and cloud applications has given Oracle the opportunity to build and scale its cloud infrastructu

    4/6/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Broadcom Announces Planned Chief Financial Officer Transition

    Amie Thuener, Experienced Technology Executive, to be Appointed as Chief Financial OfficerKirsten M. Spears to Retire as Chief Financial OfficerPALO ALTO, Calif., April 2, 2026 /PRNewswire/ -- Broadcom Inc. (NASDAQ:AVGO), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced the appointment of Amie Thuener as Chief Financial Officer of Broadcom, effective June 12, 2026. This appointment follows the retirement of Kirsten M. Spears as Chief Financial Officer, who will continue in her role until that time and will serve as an advisor for nine months to ensure a smooth transition. Ms. Thuener, an experienced technology

    4/2/26 4:15:00 PM ET
    $AVGO
    Semiconductors
    Technology

    Oracle Scales Up Nashville Offices to Support Rapid Growth

    New lease at the Neuhoff Development adds over 116,000 square feet to Oracle's Nashville footprintAUSTIN, Texas, March 26, 2026 /PRNewswire/ -- To accommodate future growth of its Nashville workforce, Oracle has signed a new 116,000 square foot lease within The Neuhoff District, at 1320 Adams Street. With this latest investment, Oracle will bring its office capacity in Nashville to about 2,000 seats across three locations, marking significant progress in the company's plans to create thousands of new tech jobs and become a cornerstone of the local economy. "New candidates as wel

    3/26/26 6:49:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ALNY
    $AVGO
    $CRWD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Avidity Biosciences Inc.

    SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

    11/14/24 5:46:11 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Avidity Biosciences Inc.

    SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

    11/14/24 1:22:38 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by CrowdStrike Holdings Inc.

    SC 13G/A - CrowdStrike Holdings, Inc. (0001535527) (Subject)

    11/14/24 1:22:38 PM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology